A novel mouse model for checkpoint inhibitor-induced adverse events is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 63 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: AI25640
National Cancer Institute
Grant: CA231277
National Institutes of Health
Grant: , AI013696
NIAID NIH HHS
Grant: R01 AI150597
NIAID NIH HHS
Grant: R01 AI125640
NCI NIH HHS
Grant: R21 CA231277
National Institutes of Health
Grant: 1R21CA231277-01A1
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
National Institutes of Health
Grant: 1R29AI025640-01A2
DEVELOPMENT OF TN916 INTO A MYCOPLASMA GENETIC TOOL
Lisa M. Baker autoimmunity innovation fund
Cancer Research Institute
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
Additional file 1 of Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia